Seo Dong-Cheol, Sung Ji-Min, Cho Hee-Jung, Yi Hee, Seo Kun-Ho, Choi In-Soo, Kim Dong-Ku, Kim Jin-Suk, El-Aty AM Abd, Shin Ho-Chul
Department of Veterinary Pharmacology and Toxicology College of Veterinary Medicine, Konkuk University, 1 Hwayang-dong, Kwangjin-gu, Seoul 143-701, Republic of Korea.
Mol Cancer. 2007 Nov 22;6:75. doi: 10.1186/1476-4598-6-75.
The studies on cancer-stem-cells (CSCs) have attracted so much attention in recent years as possible therapeutic implications. This study was carried out to investigate the gene expression profile of CSCs in human lung adenocarcinoma A549 cells.
We isolated CSCs from A549 cell line of which side population (SP) phenotype revealed several stem cell properties. After staining the cell line with Hoechst 33342 dye, the SP and non-side population (non-SP) cells were sorted using flow cytometric analysis. The mRNA expression profiles were measured using an Affymetrix GeneChip(R) oligonucleotide array. Among the sixty one differentially expressed genes, the twelve genes inclusive three poor prognostic genes; Aldo-keto reductase family 1, member C1/C2 (AKR1C1/C2), Transmembrane 4 L six family member 1 nuclear receptor (TM4SF1), and Nuclear receptor subfamily 0, group B, member 1 (NR0B1) were significantly up-regulated in SP compared to non-SP cells.
This is the first report indicating the differences of gene expression pattern between SP and non-SP cells in A549 cells. We suggest that the up-regulations of the genes AKR1C1/C2, TM4SF1 and NR0B1 in SP of human adenocarcinoma A549 cells could be a target of poor prognosis in anti-cancer therapy.
近年来,癌症干细胞(CSCs)的研究因其潜在的治疗意义而备受关注。本研究旨在调查人肺腺癌A549细胞中癌症干细胞的基因表达谱。
我们从A549细胞系中分离出癌症干细胞,其侧群(SP)表型显示出几种干细胞特性。用Hoechst 33342染料对细胞系进行染色后,通过流式细胞术分析对SP和非侧群(非SP)细胞进行分选。使用Affymetrix GeneChip(R)寡核苷酸阵列测量mRNA表达谱。在61个差异表达基因中,包括醛糖酮还原酶家族1成员C1/C2(AKR1C1/C2)、跨膜4 L六家族成员1核受体(TM4SF1)和核受体亚家族0 B组成员1(NR0B1)这三个预后不良基因在内的12个基因在SP细胞中相对于非SP细胞显著上调。
这是首次报道A549细胞中SP和非SP细胞之间基因表达模式的差异。我们认为人腺癌A549细胞SP中AKR1C1/C2、TM4SF1和NR0B1基因的上调可能是抗癌治疗中预后不良的一个靶点。